Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Check-Cap Ltd Ord (NQ: CHEK )

1.170 USD +0.020 (+1.74%)
Streaming Delayed Price Updated: 9:13 AM EST, Mar 5, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Check-Cap Ltd Ord

< Previous 1 2 3 Next >
Check-Cap Initiates U.S. Pilot Study of C-Scan® for Colorectal Cancer Screening
Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKW), (NASDAQ: CHEKZ), a clinical-stage medical diagnostics company advancing the development of C-Scan®, the first and only... 
From PR Newswire
Check-Cap Reports Fourth Quarter and Full-Year 2018 Financial Results
Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKW), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan®, the first and only... 
From PR Newswire
Check-Cap Announces Appointment of Mira Rosenzweig as Chief Financial Officer
Check-Cap Ltd. (the "Company" or "Check-Cap") (Nasdaq: CHEK) (Nasdaq: CHEKW), (Nasdaq: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan®, the first and only... 
From PR Newswire
Check-Cap Announces Institutional Review Board Approval to Initiate U.S. Pilot Study of C-Scan®
Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKW), (NASDAQ: CHEKZ), a clinical-stage medical diagnostics company advancing the development of C-Scan®, the first and only... 
From PR Newswire
Check-Cap Ltd. Announces Closing of $7.5 Million Registered Direct Offering
Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKW), (NASDAQ: CHEKZ), a clinical-stage medical diagnostics company offering C-Scan®, the first and only preparation free... 
From PR Newswire
Check-Cap Ltd. Announces $7.5 Million Registered Direct Offering
Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKW), (NASDAQ: CHEKZ), a clinical-stage medical diagnostics company offering C-Scan®, the first and only preparation free... 
From PR Newswire
Check-Cap Announces FDA Conditional Approval of IDE to Initiate U.S. Pilot Study of C-Scan®
Study to begin upon review and approval of Institutional Review Board (IRB) 
From PR Newswire
Analysis: Positioning to Benefit within Autoliv, Science Applications International, Trecora Resources, Ardmore Shipping, Check-Cap, and Sharps Compliance — Research Highlights Growth, Revenue, and Co
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Autoliv, Inc.... 
From GlobeNewswire News Releases
Check-Cap Reports Third Quarter 2018 Financial Results
Announced Interim Results from Post-CE Approval Study of C-Scan® 
From PR Newswire
Check-Cap Announces IDE Submission to FDA for Its C-Scan® System
If Approved, U.S. Pilot Study Anticipated to Commence in 4Q 2018 
From PR Newswire
Check-Cap Receives Approval From the Israeli Ministry of Health to Initiate Commercial Sales in Israel of its C-Scan® System
Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKW) (NASDAQ: CHEKZ), a clinical-stage medical diagnostics company engaged in the development of C-Scan®, an ingestible capsule... 
From PR Newswire
Check-Cap Announces Promising Interim Results from its Ongoing Post-CE Approval Study of C-Scan® System Version 3
Management to present a corporate overview at the 20th Annual Rodman & Renshaw Global Investment Conference on Wednesday, September 5 at 3:00pm ET 
From PR Newswire
Check-Cap Announces Participation at the 20th Annual Rodman & Renshaw Global Investment Conference
Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKW) (NASDAQ: CHEKZ), a clinical stage medical diagnostics company engaged in the development of C-Scan®, an ingestible... 
From PR Newswire
Check-Cap Reports Second Quarter 2018 Financial Results
Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKW) (NASDAQ: CHEKZ), a clinical stage medical diagnostics company engaged in the development of C-Scan®, an ingestible... 
From PR Newswire
Check-Cap Announces Presentation on Feasibility of Prepless CRC Screening at Digestive Disease Week 2018
Check-Cap Ltd. (the “Company” or “Check-Cap”) (NASDAQ: CHEK, CHEKW, CHEKZ), a clinical stage medical diagnostics company engaged in the development of C-Scan®, an ingestible capsule preparation-free,... 
From GlobeNewswire News Releases
Check-Cap Announces Presentation on Feasibility of Prepless CRC Screening at Digestive Disease Week 2018
From NewMediaWire
Check-Cap to Present at the 8th Annual LD Micro Invitational
From ACCESSWIRE
Check-Cap Announces Publication of CE Mark Multicenter Clinical Study Results on C-Scan® in Gut
Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKW) (NASDAQ: CHEKZ), a clinical stage medical diagnostics company engaged in the development of C-Scan®, an ingestible capsule... 
From PR Newswire
Check-Cap Reports First Quarter 2018 Financial Results
From PR Newswire
Check-Cap Announces Closing of $20.2 Million Public Offering and Full Exercise of the Underwriter's Option to Purchase Additional Securities
Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK; CHEKW; CHEKZ), a clinical-stage medical diagnostics company engaged in the development of C-Scan®, an ingestible capsule for... 
From PR Newswire
Check-Cap Announces Pricing of $17.5 Million Upsized Underwritten Public Offering
From NewMediaWire
Check-Cap Announces Pricing of $17.5 Million Upsized Underwritten Public Offering
Check-Cap Ltd. (the “Company” or “Check-Cap”) (NASDAQ: CHEK, CHEKW, CHEKZ), a clinical-stage medical diagnostics company engaged in the development of C-Scan®, an ingestible capsule for... 
From GlobeNewswire News Releases
Check-Cap Regains Compliance With Nasdaq Minimum Bid Price Requirement
Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK; CHEKW), a clinical-stage medical diagnostics company engaged in the development of C-Scan®, an ingestible capsule for preparation-free,... 
From PR Newswire
Check-Cap Files Annual Report for the Year Ended December 31, 2017
Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company developing a capsule-based system for preparation-free, colorectal cancer screening,... 
From PR Newswire
Check-Cap Reports Fourth Quarter and Full Year 2017 Financial Results
Announces the achievement of key validation milestones in C-Scan® system clinical and regulatory pathway 
From PR Newswire
Check-Cap Initiates EU Post Approval Study Using Advanced C-Scan®
Advanced C-Scan Demonstrated Significant Improvement in Average Colon Imaging Coverage in Interim Clinical Evaluation 
From PR Newswire
Check-Cap Appoints Alex Ovadia as Chief Executive Officer
Global Operations and R&D Veteran Brings Focus to C-Scan® Commercial Pathway 
From PR Newswire
Check-Cap Announces Receipt of Nasdaq Minimum Bid Price Notification
Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK, CHEKW), a clinical-stage medical diagnostics company engaged in the development of C-Scan®, an ingestible capsule for preparation-free,... 
From PR Newswire
Check-Cap Receives CE Mark Approval for C-Scan®
Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKW), a clinical-stage medical diagnostics company engaged in the development of C-Scan®, an ingestible capsule for... 
From PR Newswire
Check-Cap Announces Advancement in GE Healthcare Manufacturing Collaboration
New Phase Supports C-Scan® Assembly, Testing & Distribution Initially for US Pilot Trial 
From PR Newswire
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.